PEDIATRICS Vol. 78 No. 2 August 1986, pp. 338-348
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Glueck, C. J.
Right arrow Articles by Laskarzewski, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Glueck, C. J.
Right arrow Articles by Laskarzewski, P.

Safety and Efficacy of Long-Term Diet and Diet Plus Bile Acid-Binding Resin Cholesterol-Lowering Therapy in 73 Children Heterozygous for Familial Hypercholesterolemia

Charles J. Glueck MD1, Margot J. Mellies MD1, Mark Dine MD1, Tammy Perry 1, and Peter Laskarzewski PhD1

1 From the Lipid Research, General Clinical Research, and General Clinical Research CLINFO Centers, Departments of Medicine and Pediatrics, University of Cincinnati College of Medicine, Cincinnati

Our specific aim was to examine the efficacy and safety of long-term cholesterol-lowering diet and bile acid-binding resin therapy in 73 children heterozygous for familial hypercholesterolemia (FH). We prospectively followed accretion of height and weight in 40 FH children for 5.8 years on diet alone and in 33 FH children for 4.3 years on diet and bile acid-binding resins (8 to 20 g/d). In 67 of these 73 children, sequential data on plasma choleterol lowering was obtained, including 32 children on diet plus bile acid-binding resins and 35 on diet alone. For all 73 children, median age, sex, and race-specific percentiles for height and weight at entry were 50 and 50, respectively, and, 5.7 years later, were unchanged at 50 and 50. Initial and final percentiles for height (r = .76, P < .001) and weight (r = .70, P < .001) were closely correlated. Percentile distributions for height and weight at entry into the study did not differ from those at the end of follow-up (P > .1), in both the 40 FH children on diet alone and the 33 on diet plus bile acid-binding resins. Tracking of height and weight did not differ in the 40 children on diet alone v the 33 on diet plus bile acidbinding resins (P > .1). During 6 years of follow-up there were no significant differences in the percentage of serial, postbaseline measurements for height which were either less than or greater than or equal to baseline percentiles, comparing 40 FH children on diet alone, 33 FH children on diet plus resin, and 39 normal children (on ad libitum diet). FH children on diet or plus resin had a smaller percentage of weight measurements equal to or more than baseline percentiles than normals on follow-up (P < .01), probably reflecting restriction of total fat intake to < 35% of calories. On diet alone, 32 FH children had total plasma cholesterol of 307 ± 8 mg/dL (mean ± SE); bile acidbinding resins were added to diet in these children at an average age of 11.5 years, with this regimen maintained for 4.6 ± 0.4 years, leading to a mean reduction in total plasma cholesterol of 12.5% ± 2% beyond the effects of diet alone (P<.01). On diet plus bile acid-binding resins, 44% of children had a reduction of total plasma cholesterol le14%; 28% had a reduction ge21% (beyond the effects of diet alone.) Thirty-five FH children (starting at 11.7 years of age) were treated with diet alone. Their mean total plasma cholesterol at baseline was 243 ± 6 mg/dl and decreased 9.6% ± 2% (P<.01) after an average of 4.5 ± 0.5 years of diet. On diet alone, 29% of children had a reduction of total plasma cholesterol ge14%, and 23% had a reduction ge21%. Long-term diet and bile acid-binding resin therapy did not affect normal growth in 73 FH children and was effective in reducing total plasma cholesterol levels within ranges previously shown to have efficacy in reducing coronary heart disease events in hypercholesterolemic men.

Key Words: familial hypercholesterolemia • diet • bile acid-binding resins

Submitted on December 5, 1985
Accepted on December 23, 1985




This article has been cited by other articles:


Home page
 PediatricsHome page
E. M. Haney, L. H. Huffman, C. Bougatsos, M. Freeman, R. D. Steiner, and H. D. Nelson
Screening and Treatment for Lipid Disorders in Children and Adolescents: Systematic Evidence Review for the US Preventive Services Task Force
Pediatrics, July 1, 2007; 120(1): e189 - e214.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
A. Wiegman, J. Rodenburg, S. de Jongh, J. C. Defesche, H. D. Bakker, J. J.P. Kastelein, and E. J.G. Sijbrands
Family History and Cardiovascular Risk in Familial Hypercholesterolemia: Data in More Than 1000 Children
Circulation, March 25, 2003; 107(11): 1473 - 1478.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
O. Simell, H. Niinikoski, T. Ronnemaa, H. Lapinleimu, T. Routi, H. Lagstrom, P. Salo, E. Jokinen, and J. Viikari
Special Turku Coronary Risk Factor Intervention Project for Babies (STRIP)
Am. J. Clinical Nutrition, November 1, 2000; 72 (5): 1316S - 1331S.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
M. Gracey
Historical, cultural, political, and social influences on dietary patterns and nutrition in Australian Aboriginal children
Am. J. Clinical Nutrition, November 1, 2000; 72 (5): 1361S - 1367S.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
H. Niinikoski, J. Viikari, T. Ronnemaa, H. Helenius, E. Jokinen, H. Lapinleimu, T. Routi, H. Lagstrom, R. Seppanen, I. Valimaki, et al.
Regulation of Growth of 7- to 36-Month-Old Children by Energy and Fat Intake in the Prospective, Randomized STRIP Baby Trial
Pediatrics, November 1, 1997; 100(5): 810 - 816.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
H. Niinikoski, H. Lapinleimu, J. Viikari, T. Ronnemaa, E. Jokinen, R. Seppanen, P. Terho, J. Tuominen, I. Valimaki, and O. Simell
Growth Until 3 Years of Age in a Prospective, Randomized Trial of a Diet With Reduced Saturated Fat and Cholesterol
Pediatrics, May 1, 1997; 99(5): 687 - 694.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
C Holden
NIH moves to debar cholesterol researcher
Science, August 14, 1987; 237(4816): 718 - 719.
[PDF]